Saturday, November 18 2017

VietNamNews

Abbott’s 2016 earnings in VN touch $434 million

Update: May, 26/2017 - 15:00
Việt Nam is among top 10 profitable markets of Abbott. — Photo Courtesy of VFA
Viet Nam News

HÀ NỘI — Global healthcare company Abbott recorded net sales of US$434 million in the Vietnamese market last year, the company’s 2016 annual report revealed. Việt Nam is among top 10 profitable markets of Abbott.

The company’s revenue in 2014 and 2015 were $357 million and $331 million, respectively.

Abbott set up an office in HCM City in 1995, and now has around 100 employees in Việt Nam. Its main products in the Vietnamese market are milk powders such as Ensure, Pediasure, Similac and Grow.

In 2016, Abbott acquired leading Vietnamese drug manufacturer Glomed Pharmaceutical Company Inc (Glomed) and two drug factories in the southern province of Bình Dương.

Abbott also has 52 per cent indirect ownership in Domesco Medical Import Export Joint Stock Corporation through its subsidiary CFR International SPA. — VNS

Abbott’s annual report 2016 recorded net sales of US$434 million in the Vietnamese market last year. — Photo Abbott

Send Us Your Comments:

See also: